Serum levels of interleukin-8, tumor necrosis factor-α and γ-interferon in Egyptian psoriatic patients and correlation with disease severity

Journal of Dermatology

Volumn 38, Issue 5, 2011, Pages 442-446

  Abdel Hamid, Mahmoud F ^a   Aly, Dalia G ^a,b   Saad, Nevine E ^a   Emam, Hanaa M ^a   Ayoub, Dina F ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b NONE   (Egypt)

Author keywords

interferon; interleukin 8; psoriasis; Psoriasis Area and Severity Index; tumor necrosis factor

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE MARKER; DISEASE SEVERITY; EGYPT; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; PSORIASIS; PSORIASIS SEVERITY INDEX; RECEIVER OPERATING CHARACTERISTIC; SCHOOL CHILD; SKIN INDURATION; TH1 CELL;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CHILD; EGYPT; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-8; MALE; MIDDLE AGED; PSORIASIS; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 79955378160     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2010.01018.x     Document Type: Article

References (15)

1. Hedrick MN, Lonsdorf AS, Shirakawa AK, et al. CCR6 is required for IL-23-induced psoriasis-like inflammation in mice. J Clin Invest 2009; 119 (8): 2317-2329.
2. Yao Y, Richman L, Morehouse C, et al. Type I interferon: potential therapeutic target for psoriasis? PLoS ONE 2008; 3 (7): e2737. [Erratum, PLoS ONE 2009; 4 (3).]
3. Mehlis SL, Gordon KB,. The immunology of psoriasis and biological immunotherapy. J Am Acad Dermatol 2003; 49 (Suppl): S44-S50.
4. Takahashi H, Tsuji H, Hashimoto Y, Ishida-Yamamoto A, Iizuka H,. Serum cytokines and growth factor levels in Japanese patients with psoriasis. Clin Exp Dermatol 2010; 35: 645-649. [Epub ahead of print].
5. Jacob SE, Nassiri M, Kerdel FA, Vincek V,. Simultaneous measurement of multiple Th1 and Th2 serum cytokines in psoriasis and correlation with disease severity. Mediators Inflamm 2003; 12 (5): 309-313. (Pubitemid 37392904)
6. Arican O, Aral M, Sasmaz S, Ciragil P,. TNF-α, IFN-γ, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators Inflamm 2005; 5: 273-279. (Pubitemid 41577417)
7. Almakhzangy I, Gaballa A,. Serum level of IL-17, IL-22, IFN-γ in patients with psoriasis. Egypt Dermatol Online J 2009; 5 (1): 4.
8. Fredriksson T, Pettersson U,. Severe psoriasis-oral therapy with a new retinoid. Dermatologica 1978; 157: 238-244. (Pubitemid 8387357)
9. Varghese B, et al. Study of serum cytokine profile in psoriasis and the effect of treatment. ICD 2009; Book of Abstracts. 461.
10. Jain S, Kaurl IR, Das S, Bhattacharya SN, Singh A,. T helper 1 to T helper 2 shift in cytokine expression: an autoregulatory process in superantigen-associated psoriasis progression? J Med Microbiol 2009; 58: 180-184.
11. Nestle FO, Kaplan DH, Barker J,. Psoriasis. N Engl J Med 2009; 361 (5): 496-509.
12. Aronson PJ,. A review of the role of neutrophils in psoriasis and related disorders. Dermatol Online J 2008; 14 (7).
13. Sticherling M, Sautier W, Schroder JM, Christophers E,. Interleukin-8 plays its role at local level in psoriasis vulgaris. Acta Derm Venereol 1999; 79 (1): 4-8. (Pubitemid 29079319)
14. Gomi T, Shiohara T, Munakata T, et al. Interleukin 1a, tumor necrosis factor-α, and interferon-γ in psoriasis. Arch Dermatol 1991; 127: 827-830.
15. Fitch E, Harper E, Iliyana Skorcheva I, Kurtz SE, Blauvelt A,. Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines. Curr Rheumatol Rep 2007; 9: 461-467. (Pubitemid 350305203)